CD8A and neoplasm: Activated CD4+ T cells promote the differentiation of TAA-specific cytotoxic CD8+ T cells, which subsequently migrate back to the tumor site to orchestrate the targeted killing of residual malignant cells (Shoaf and Desjardins 2022).